New Tool Aims to Prioritize High-Risk Infants for RSV Immunization
On the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, exciting new research reveals a promising tool that could pinpoint newborns most at risk for severe RSV LRTI